Verano Holdings Corp. ( VRNO) - Key Metrics
VRNO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.58 | -$0.51 | $0.04 | $0.01 |
| 2025Q3 | $0.55 | -$0.12 | $0.07 | $0.05 |
| 2025Q2 | $0.56 | -$0.05 | $0.03 | $0 |
| 2025Q1 | $0.58 | -$0.03 | $0 | -$0.03 |
VRNO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -0.61 |
| 2025Q3 | ? | -2.88 |
| 2025Q2 | ? | -2.34 |
| 2025Q1 | ? | -5.07 |
VRNO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.89% | ? |
| 2025Q4 | 0.97% | ? |
| 2025Q3 | 3.82% | ? |
| 2025Q2 | 0.24% | ? |
| 2025Q1 | -5.17% | ? |
VRNO
Price: $1.10
52 week price:
Earnings Per Share: -0.99 USD
P/E Ratio: -1.08
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 422.7 million